News

Glenmark Pharmaceuticals to launch Brukinsa (zanubrutinib) in India after DCGI approval, offering treatment for five B-cell blood cancers with fewer cardiac side effects and flexible dosing options.
Glenmark shares on Monday ended 0.68% up at ₹1,600.85 apiece on BSE. New Delhi: Glenmark Pharmaceuticals on Monday said it will launch cancer treatment drug zanubrutinib in India following ...
Owner Tony Ottobre has hinted star mare Pride Of Jenni is likely to continue her racing career in the spring and will stick to races over a mile. The seven-year-old was last seen in the Doomben Cup ...
A decision on Pride Of Jenni's immediate future will be made in the coming days, with the superstar mare having an easy time in Queensland since her Doomben Cup defeat. The triple Group 1 winner, who ...
Glenmark-Ichnos cancer drug shows 74% response in phase-1 trial The early-stage trial results signal promise for ISB 2001, a first-in-class trispecific antibody being developed for patients with ...
JENNI MURRAY: JD Vance should keep his nose out of British women's business. By JENNI MURRAY, COLUMNIST FOR FEMAIL MAGAZINE. Published: 11:56 EDT, 4 June 2025 | Updated: 17:00 EDT, 4 June 2025 ...
“Pressure is mounting on Conservative Leader Pierre Poilievre to fire Jenni Byrne, his national campaign manager,” according to a May 22 CBC News piece, “whom critics hold responsible for ...
Glenmark’s myeloma drug delivers high response in phase-1 trial At active dose levels (≥ 50 µg/kg), 26 of 33 evaluable patients (79%) achieved objective responses, including stringent or ...
Glenmark Pharmaceuticals Ltd Summary. Glenmark Pharmaceuticals Limited was incorporated on November 18, 1977. The Company is actively involved in the discovery of new molecules both NCEs (new ...
Jenni added that she could never understand how or why Angelina demeaned them on her podcast after having a fun vacation with them in Miami. "It was really hurtful," she added.
Check out our GLENMARK stock chart to see a history of performance, current stock value, and a timeline of financial events & indicators for a full analysis today.